Health
Jonathan Wall receives $1.79 million to develop new amyloidosis treatment – EurekAlert
The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science…
IMAGE: Dr. Jonathan Wall
view more
Credit: UTHSC
Memphis, Tenn. (March 16, 2021) – The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.”
Amyloidosis is a rare disease that occurs when abnormal protein aggregates (called amyloid)…
-
Noosa News18 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store
-
Noosa News23 hours agoFather found stabbed dead upstairs at teenagers’ Brisbane house party
-
Noosa News23 hours agoSA ban on plastic produce stickers on hold as growers struggle with costs
-
General23 hours agoJim Chalmers will have to juggle competing demands to secure tax reform